Yale-New Haven Biotechnology Enterprise Forum Talk Will Focus on University-based Technology Incubators
Jonathan Gorham, managing partner of Gorham Associates, will be the next speaker in the Yale-New Haven Biotechnology Enterprise Forum series. His talk, titled “University Based Technology Incubators and Venture Funds,” will be presented Tuesday, March 3, from 4:30-6:30 p.m in Bass Hall at the Bass Center for Molecular and Structural Biology, 266 Whitney Ave. Refreshments will be served in the foyer outside Bass Hall from 4-4:30 p.m.
Gorham founded Gorham Associates in 1997. His firm specializes in economic development consulting and management of innovation centers. He and his team have played a leading role in the establishment of several such centers, including the Center for Design Innovation at F.I.T. in New York City, and Mass Ventures, a technology incubator on the campus of the University of Massachusetts at Amherst.
Prior to his current position, Gorham was co-founder and managing partner of Science Park Associates, a consulting firm affiliated with Science Park in New Haven, where he helped raise more than $6 million and developed a nationally acclaimed job-creation project for neighborhood residents. He received his B.A. and M.A.T. degrees from Harvard University, and a master’s degree in public and private management from Yale University.
Gorham has been a consultant for more than 50 colleges, universities, cities, states and economic development organizations, including Yale Medical Center Inc., the University of Missouri at Columbia, the University of Colorado at Boulder, the University of Nebraska at Lincoln and the University of Massachusetts at Lowell. He also has been a consultant for the U.S. Dept. of Defense, and Chambers of Commerce in Wausau, Wis.; Lima, Ohio; and Ogden, Utah.
The founder of three early-stage companies in the energy conservation field, Gorham developed an industry association-sponsored course titled “Testing Feasibility and Managing Incubators” and trained more than 800 economic development professionals.
Sponsored by The Biotech Committee of Greater New Haven and the Yale University Office of Cooperative Research, the Yale-New Haven Biotechnology Enterprise Forum series focuses on commercial development of biotechnology and is geared toward entrepreneurs and university scientists. All talks in the series are open to the public free of charge.
The final talk in the series will be April 7. Gualberto Ruano, co-founder and chief executive officer of Genaissance, a New Haven-based biotechnology company focused on pharmacogenomics, will speak on “Genomic Strategies and Drug Discovery” in the Hope Conference Room, Sterling Hall of Medicine, 333 Cedar St. Dr. Ruano received a B.S. degree from Johns Hopkins University, a Ph.D. degree in human genetics from Yale, and his M.D. degree from the Yale University School of Medicine.
For more information, please call the Yale Office of Cooperative Research at (203) 432-5446.